• Conclusion This pharmaceutical preparation is up to the quality of capsule.

    结论制剂符合胶囊剂质量要求。

    youdao

  • The stability of a new pharmaceutical preparation, isosorbide dinitrate pills, was studied.

    对新研制的硝酸异山梨酯滴丸进行稳定性实验研究。

    youdao

  • The invention provides a new drug for treating hemorrhoid and a pharmaceutical preparation method.

    本发明提供了一种治疗痔疮的新药物及其药物制剂制备方法。

    youdao

  • A therapeutic serum is a pharmaceutical preparation that contains antibodies against one or more specific antigens.

    治疗血清是一种药物制剂,含有针对一种或多种特定抗原的抗体。

    youdao

  • Sale and distribution of pharmaceutical intermediates, API, pharmaceutical preparation and medical consumables.

    经营医药中间体,原料药,西药制剂,医疗耗材。

    youdao

  • They are applied in photoelectricity transducer, liquid crystal, micelle, catalyst, pharmaceutical preparation, light curing coat, etc.

    在光电传感、液晶、胶束、催化剂、药物制剂和光固化涂料等多方面有广阔的应用。

    youdao

  • The composition and pharmaceutical preparation of the present invention is effective in the treatment and prevention of dry eye syndrome.

    本发明的组合物和药物制剂对干眼综合征的治疗和预防有效。

    youdao

  • The invention relates to a radix astragali pharmaceutical preparation, in particular to a method for preparing a radix astragali total saponin sodium chloride injection.

    本发明涉及一种黄芪医药制剂,具体为一种黄芪总皂苷氯化钠注射液的制备方法。

    youdao

  • The invention relates to a pharmaceutical composition for reducing myocardial infarction area, and a pharmaceutical preparation containing the same and an application thereof.

    本发明涉及一种用于预防和治疗缩小心肌梗死面积的药物组合物和含其的 药物制剂和用途。

    youdao

  • Pharmaceuticals and Chemicals Industry: producing pharmaceutical preparation, medicine, finished medicines, vitamin, RE (rare-earth) electron, industry of fine chemicals and so on.

    医药化工产业:以生产医药制剂,成品药,医药中间体,维生素以及稀土电子,精细化工产品等为主。

    youdao

  • The pharmaceutical preparation comprises various preparations in different administration routes, such as oral taking, injection, cavity taking, subcutaneous injection, and the like.

    本发明所述的药物剂型包括各种口服、注射、腔道、经皮等不同给药途径的药物制剂。

    youdao

  • The pharmaceutical preparation room in a hospital mostly adopts selecting suitable empty capsules after trial-stuffing manually or trial-stuffing from experience using a model plate.

    医院制剂室生产诺氟沙星胶囊多采用手工或模板凭经验试装后再选用适宜型号的空胶囊,这样进行空胶囊填充诺氟沙星和赋形剂时具有一定的困难。

    youdao

  • New 2,3-dioxide, indanol compounds, process for their preparation and pharmaceutical compositions containing them.

    新的2,3-二氢化茚醇化合物,其制备方法和包含它们的药物组合物。

    youdao

  • Pharmaceutical Drug Room different characteristics to the needs of the market, research and development for pharmaceutical production, storage, transport, Sales and use of the preparation method.

    药物制剂室根据药物的不同特性,结合市场的需要,研究开发适合药品生产,保存,运输,销售和使用的制剂方法。

    youdao

  • Carrier particle for a microorganism or subunit thereof, pharmaceutical composition comprising such particles, method for preparation of this composition and its use in the treatment of animals.

    用于微生物或其亚单位的载体颗粒,含有该颗粒的药物组合物,该组合物的制备方法及其在动物治疗中的用途。

    youdao

  • Methods:A literature research methods and research methods comparison study the statement of Chinese and Japanese pharmaceutical compound preparation, as well as relevant laws.

    方法:采用文献研究方法和比较研究方法,研究中日两国中药复方制剂药品说明书以及相关法律。

    youdao

  • Gastrodine derivative, its preparation method, pharmaceutical composition and USES.

    天麻素衍生物,其制备方法,药物组合物及其用途。

    youdao

  • Quinazoline derivatives, pharmaceutical composition containing the compound, their utilization and preparation method thereof.

    喹唑啉衍生物,含该化合物的药物组合物,其用途及其制备方法。

    youdao

  • Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical USES, and methods and intermediates useful for their preparation.

    金属蛋白酶抑制剂,含有它们的药物组合物和其药物用途,其制备方法和中间体。

    youdao

  • Inhibitors of metalloproteinase, pharmaceutical compositions containing them, their pharmaceutical application and methods and intermediate compounds for their preparation.

    金属蛋白酶抑制剂,含有它们的药物组合物和其药物用途,其制备方法和中间体。

    youdao

  • Steroids including a spiro ring in position 17, the process and the intermediates for their preparation, their use as medicaments, and the pharmaceutical compositions containing them.

    一种在位置17含有螺环的新的甾族化合物,它的生产方法及中间产物,它作为药剂的应用,以含有该化合物的医药用组合物。

    youdao

  • We also have analyzed the advantages, disadvantages, chances, and challenges to Shijiazhuang Pharmaceutical Group Company Co. Ltd. Preparation Branch by SWOT analysis method.

    利用SWOT分析方法,详尽分析了石药集团制剂分公司的优势、劣势、机会和威胁。

    youdao

  • The invention discloses a pharmaceutical composition with a function of improving the memory and a preparation method thereof.

    本发明公开了一种具有改善记忆力功能的药物组合物及其制备方法。

    youdao

  • The invention discloses a pharmaceutical composition with functions of radiation resistance and immunity enhancement and a preparation method thereof.

    本发明公开了一种具有抗辐射、增强免疫力功能的药物组合物及其制备方法。

    youdao

  • The invention further provides a preparation method of the compounds, a pharmaceutical composition containing the compounds, and use of the compounds, in particular antitumor use.

    本发明还提供了上述化合物的制备方法、含有它们的药物组合物以及它们的用途,特别是抗肿瘤的用途。

    youdao

  • The present invention describes the use of trifunctional bispecific antibodies for the preparation of a pharmaceutical composition for the prophylaxis and treatment of tumor diseases.

    本发明描述了三官能双特异性抗体用于制备用来预防和治疗肿瘤疾病的药物组合物的应用。

    youdao

  • The invention discloses a pharmaceutical composition for treating cardiovascular diseases and a preparation method thereof.

    本发明公开了一种治疗心血管疾病的药物组合物及其制备方法。

    youdao

  • This invention relates to a novel crystalline polymorphic form of nemorubicin hydrochloride dihydrate, useful for the preparation of pharmaceutical composition for the treatment of tumors.

    本发明涉及一种新的晶体多晶形式的二水合盐酸奈莫柔比星,用于制备治疗癌症的药物组合物。

    youdao

  • The invention relates to novel specifically trifluoromethyl and halogen substituted 1,3-diphenyl ureas and their use as active ingredients in the preparation of pharmaceutical compositions.

    本发明涉及新的特别由三氟甲基和卤素取代的1,3-二苯基脲,以及它们在药物组合物的制备中作为活性成分的用途。

    youdao

  • The invention relates to novel specifically trifluoromethyl and halogen substituted 1,3-diphenyl ureas and their use as active ingredients in the preparation of pharmaceutical compositions.

    本发明涉及新的特别由三氟甲基和卤素取代的1,3-二苯基脲,以及它们在药物组合物的制备中作为活性成分的用途。

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定